223 related articles for article (PubMed ID: 26305481)
21. Effects of insulin-like growth factors (IGF) on pancreatic islet function in IGF binding protein-1 transgenic mice.
Dheen ST; Rajkumar K; Murphy LJ
Diabetologia; 1996 Nov; 39(11):1249-54. PubMed ID: 8932988
[TBL] [Abstract][Full Text] [Related]
22. Metallothionein induction in islets of Langerhans and insulinoma cells.
Laychock SG; Duzen J; Simpkins CO
Mol Cell Endocrinol; 2000 Jul; 165(1-2):179-87. PubMed ID: 10940496
[TBL] [Abstract][Full Text] [Related]
23. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
[TBL] [Abstract][Full Text] [Related]
24. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
Paulsen SK; Pedersen SB; Jørgensen JO; Fisker S; Christiansen JS; Flyvbjerg A; Richelsen B
J Clin Endocrinol Metab; 2006 Mar; 91(3):1093-8. PubMed ID: 16368752
[TBL] [Abstract][Full Text] [Related]
26. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice.
Yuan X; Li H; Bai H; Zhao X; Zhang C; Liu H; Zhang Y; Zhao B; Wu Y; Liu J; Xiang Q; Feng B; Chu Y; Huang Y
Eur J Pharmacol; 2016 Oct; 788():140-151. PubMed ID: 27242185
[TBL] [Abstract][Full Text] [Related]
27. Regulation of glucocorticoid sensitivity in thymocytes from burn-injured mice.
D'Elia M; Patenaude J; Bernier J
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E97-104. PubMed ID: 19001548
[TBL] [Abstract][Full Text] [Related]
28. 11β-HSD1 contributes to age-related metabolic decline in male mice.
Morgan SA; Gathercole LL; Hassan-Smith ZK; Tomlinson J; Stewart PM; Lavery GG
J Endocrinol; 2022 Dec; 255(3):117-129. PubMed ID: 36205523
[TBL] [Abstract][Full Text] [Related]
29. The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities.
Zhang TY; Ding X; Daynes RA
J Immunol; 2005 Jan; 174(2):879-89. PubMed ID: 15634910
[TBL] [Abstract][Full Text] [Related]
30. IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin.
Chowdhury S; Wang X; Srikant CB; Li Q; Fu M; Gong YJ; Ning G; Liu JL
Endocrinology; 2014 May; 155(5):1629-42. PubMed ID: 24552398
[TBL] [Abstract][Full Text] [Related]
31. Local amplification of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes.
Gilmour JS; Coutinho AE; Cailhier JF; Man TY; Clay M; Thomas G; Harris HJ; Mullins JJ; Seckl JR; Savill JS; Chapman KE
J Immunol; 2006 Jun; 176(12):7605-11. PubMed ID: 16751407
[TBL] [Abstract][Full Text] [Related]
32. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological evaluation of adipose dysfunction via 11β-hydroxysteroid dehydrogenase type 1 in the development of diabetes in diet-induced obese mice with cortisone pellet implantation.
Akiyama N; Akiyama Y; Kato H; Kuroda T; Ono T; Imagawa K; Asakura K; Shinosaki T; Murayama T; Hanasaki K
J Pharmacol Exp Ther; 2014 Apr; 349(1):66-74. PubMed ID: 24511146
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
Candia R; Riquelme A; Baudrand R; Carvajal CA; Morales M; Solís N; Pizarro M; Escalona A; Carrasco G; Boza C; Pérez G; Padilla O; Cerda J; Fardella CE; Arrese M
Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.
Paterson JM; Morton NM; Fievet C; Kenyon CJ; Holmes MC; Staels B; Seckl JR; Mullins JJ
Proc Natl Acad Sci U S A; 2004 May; 101(18):7088-93. PubMed ID: 15118095
[TBL] [Abstract][Full Text] [Related]
36. Human IGF binding protein-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion.
Nguyen KH; Yao XH; Moulik S; Mishra S; Nyomba BL
Endocrinology; 2011 Jun; 152(6):2184-96. PubMed ID: 21447640
[TBL] [Abstract][Full Text] [Related]
37. Short-term glucocorticoid treatment increases insulin secretion in islets derived from lean mice through multiple pathways and mechanisms.
Hult M; Ortsäter H; Schuster G; Graedler F; Beckers J; Adamski J; Ploner A; Jörnvall H; Bergsten P; Oppermann U
Mol Cell Endocrinol; 2009 Mar; 301(1-2):109-16. PubMed ID: 18984029
[TBL] [Abstract][Full Text] [Related]
38. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.
Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301
[TBL] [Abstract][Full Text] [Related]
39. A novel promoter for the 11beta-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPalpha independent.
Bruley C; Lyons V; Worsley AG; Wilde MD; Darlington GD; Morton NM; Seckl JR; Chapman KE
Endocrinology; 2006 Jun; 147(6):2879-85. PubMed ID: 16543369
[TBL] [Abstract][Full Text] [Related]
40. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
Tagawa N; Kubota S; Kobayashi Y; Kato I
Steroids; 2015 Jan; 93():77-86. PubMed ID: 25447798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
